---
schema_version: "secwatch.filing_event.v1"
accession: "0001650664-26-000063"
form_type: "8-K"
ticker: "EDIT"
cik: "0001650664"
company_name: "Editas Medicine, Inc."
filed_at: "2026-06-18T20:28:44+00:00"
generated_at: "2026-06-18T20:34:05.129587+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Editas Medicine holds 2026 annual meeting; elects two Class I directors and ratifies auditor

## Summary
- Stockholders elected Bernadette Connaughton (28.66M for, 10.79M withheld) and Elliott Levy, M.D. (37.10M for, 2.35M withheld) as Class I directors.
- Non-binding advisory vote on named executive officer compensation passed with 32.91M for, 6.32M against, 0.21M abstain.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for FY2026 approved with 64.69M for, 0.77M against, 0.39M abstain.

## SEC filing metadata
- accession: 0001650664-26-000063
- form_type: 8-K
- ticker: EDIT
- cik: 0001650664
- company_name: Editas Medicine, Inc.
- filed_at: 2026-06-18T20:28:44+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650664/000165066426000063/0001650664-26-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650664/000165066426000063/edit-20260617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001650664-26-000063
- JSON: https://secwatch.observer/filing/0001650664-26-000063.json
- Plain text: https://secwatch.observer/filing/0001650664-26-000063.txt

## Key facts
- Shareholder Votes
  Editas Medicine, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-17 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: The Company’s stockholders approved, on an advisory basis, the compensation paid to its named executive officers. The results of the stockholders’ non-binding, advisory vote with respect to compensation paid to the Company’s named executive officers were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 32,914,258 6,322,885 212,587 26,404,190
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000165066426000063/0001650664-26-000063-index.htm
- Shareholder Votes
  Editas Medicine, Inc. shareholders approved Election of Class I directors at the 2026-06-17 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: The Company’s stockholders elected Bernadette Connaughton and Elliott Levy, M.D., to serve as Class I directors until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The results of the stockholders’ vote with respect to the election of such Class I directors were as follows: Votes For Votes Withheld Broker Non-Votes Bernadette Connaughton 28,660,181 10,789,549 26,404,190 Elliott Levy, M.D. 37,095,058 2,354,672 26,404,190
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000165066426000063/0001650664-26-000063-index.htm
- Shareholder Votes
  Editas Medicine, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent auditor at the 2026-06-17 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: The Company’s stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the stockholders’ vote with respect to such ratification were as follows: Votes For Votes Against Votes Abstaining Broker Non-Votes 64,686,839 774,471 392,610 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000165066426000063/0001650664-26-000063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.